219 related articles for article (PubMed ID: 25621159)
21. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
22. Treprostinil for the treatment of pulmonary arterial hypertension.
Torres F; Rubin LJ
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension.
Channick RN; Olschewski H; Seeger W; Staub T; Voswinckel R; Rubin LJ
J Am Coll Cardiol; 2006 Oct; 48(7):1433-7. PubMed ID: 17010807
[TBL] [Abstract][Full Text] [Related]
24. Inpatient Initiation of Oral Treprostinil in an Academic Medical System.
Hohlfelder B; Tonelli AR; Heresi GA; Bair N; Rahaghi FF; Bauer SR
Cardiovasc Drugs Ther; 2020 Aug; 34(4):547-553. PubMed ID: 32424651
[TBL] [Abstract][Full Text] [Related]
25. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
26. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
Tapson VF; Jing ZC; Xu KF; Pan L; Feldman J; Kiely DG; Kotlyar E; McSwain CS; Laliberte K; Arneson C; Rubin LJ;
Chest; 2013 Sep; 144(3):952-958. PubMed ID: 23669822
[TBL] [Abstract][Full Text] [Related]
27. Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations.
Sargent T; Hansen L; Hohsfield R
Pulm Circ; 2020; 10(3):2045894020931324. PubMed ID: 32595933
[TBL] [Abstract][Full Text] [Related]
28. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
[TBL] [Abstract][Full Text] [Related]
30. INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).
Hill NS; Feldman JP; Sahay S; Benza RL; Preston IR; Badesch D; Frantz RP; Patel S; Galloway A; Bull TM;
Pulm Circ; 2022 Jul; 12(3):e12119. PubMed ID: 36034402
[TBL] [Abstract][Full Text] [Related]
31. Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension.
Burger CD; Wu B; Classi P; Morland K
J Manag Care Spec Pharm; 2023 Jan; 29(1):101-108. PubMed ID: 36580122
[No Abstract] [Full Text] [Related]
32. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
33. Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension.
Olsson KM; Richter MJ; Kamp JC; Gall H; Heine A; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
J Heart Lung Transplant; 2019 Jul; 38(7):748-756. PubMed ID: 31128966
[TBL] [Abstract][Full Text] [Related]
34. Prostacyclin for pulmonary arterial hypertension.
Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T
Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010
[TBL] [Abstract][Full Text] [Related]
35. An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension.
Zamanian RT; Levine DJ; Bourge RC; De Souza SA; Rosenzweig EB; Alnuaimat H; Burger C; Mathai SC; Leedom N; DeAngelis K; Lim A; De Marco T
Pulm Circ; 2016 Sep; 6(3):329-37. PubMed ID: 27683610
[TBL] [Abstract][Full Text] [Related]
36. Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension.
Maestas T; Hansen LM; Vanderpool RR; Desai AA; Airhart S; Knapp SM; Cohen A; Feldman J; Rischard FP
Pulm Circ; 2018; 8(4):2045894018797270. PubMed ID: 30124133
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension.
Kuwana M; Abe K; Kinoshita H; Matsubara H; Minatsuki S; Murohara T; Sakao S; Shirai Y; Tahara N; Tsujino I; Takahashi K; Kanda S; Ogo T
Pulm Circ; 2023 Jan; 13(1):e12198. PubMed ID: 36788940
[TBL] [Abstract][Full Text] [Related]
38. Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension.
Enderby CY; Burger C
Ther Adv Chronic Dis; 2018 Sep; 9(9):171-177. PubMed ID: 30181846
[TBL] [Abstract][Full Text] [Related]
39. Safety and Tolerability of a Rapid Transition From Intravenous Treprostinil to Oral Selexipag in Three Adolescent Patients With Pulmonary Arterial Hypertension.
Colglazier E; Ng AJ; Parker C; Nawaytou H; Fineman JR
J Pediatr Pharmacol Ther; 2021; 26(5):512-516. PubMed ID: 34239406
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ
Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
